Cong Wang
Impact in
- Hepatology top 10%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in ⓘ
- Epidemiology 34
- Liver Disease Diagnosis and Treatment 16
- Hepatitis B Virus Studies 4
-
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 4
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Ming Du (3 shared papers)Lanwei Zhang (2 shared papers)Weili Xu (2 shared papers)Gangyi Yang (5 shared papers)Shengfu Wang (1 shared paper)Dongfang Liu (4 shared papers)Ya Gao (1 shared paper)Xun Zhang (1 shared paper)
- Journals
- Frontiers in Psychiatry (3 papers)Scientific Reports (2 papers)Advanced Functional Materials (2 papers)The Science of The Total Environment (2 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Cong Wang
106 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Hepatology 72
- Epidemiology 302
- Molecular Biology 594
- Biochemistry 57
- Cancer Research 112
Countries citing papers authored by Cong Wang
This map shows the geographic impact of Cong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Wang more than expected).
Fields of papers citing papers by Cong Wang
This network shows the impact of papers produced by Cong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Wang. The network helps show where Cong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 107 | |
| 2 | 2013 | 93 | |
| 3 | 2015 | 87 | |
| 4 | Ulinastatin protects against acetaminophen-induced liver injury by alleviating ferroptosis via the SIRT1/NRF2/HO-1 pathway. | 2021 | 64 |
| 5 | 2017 | 63 | |
| 6 | Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis Hit paper breakdown → | 2024 | 51 |
| 7 | 2022 | 48 | |
| 8 | 2017 | 46 | |
| 9 | 2012 | 44 | |
| 10 | 2009 | 40 | |
| 11 | 2018 | 37 | |
| 12 | 2019 | 35 | |
| 13 | 2019 | 34 | |
| 14 | 2018 | 34 | |
| 15 | 2013 | 32 | |
| 16 | 2013 | 27 | |
| 17 | 2010 | 21 | |
| 18 | 2022 | 18 | |
| 19 | 2019 | 17 | |
| 20 | 2021 | 17 |
About Cong Wang
Cong Wang is a scholar working on Epidemiology, Molecular Biology, Oncology, Rheumatology and Surgery, having authored 112 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Protein Degradation and Inhibitors (5 papers), Liver physiology and pathology (4 papers), Hepatitis B Virus Studies (4 papers), Ubiquitin and proteasome pathways (4 papers), Advanced Battery Materials and Technologies (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hepatology (72 citations), Epidemiology (302 citations), Molecular Biology (594 citations), Biochemistry (57 citations) and Cancer Research (112 citations). Cong Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ming Du, Lanwei Zhang, Weili Xu, Gangyi Yang, Shengfu Wang, Dongfang Liu, Ya Gao, Xun Zhang, Jingwen Li and Wei Wen. Their work appears in journals such as Frontiers in Psychiatry, Scientific Reports, Advanced Functional Materials, The Science of The Total Environment and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.